ESMC has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
ESMC has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Escalon Medical's gross profit for the three months ended in Mar. 2024 was $1.12 Mil. Escalon Medical's gross profit for the trailing twelve months (TTM) ended in Mar. 2024 was $5.13 Mil.
Gross Margin % is calculated as gross profit divided by its revenue. Escalon Medical's gross profit for the three months ended in Mar. 2024 was $1.12 Mil. Escalon Medical's Revenue for the three months ended in Mar. 2024 was $2.70 Mil. Therefore, Escalon Medical's Gross Margin % for the quarter that ended in Mar. 2024 was 41.43%.
Escalon Medical had a gross margin of 41.43% for the quarter that ended in Mar. 2024 => Durable competitive advantage
During the past 13 years, the highest Gross Margin % of Escalon Medical was 49.07%. The lowest was 42.27%. And the median was 45.44%.
The historical data trend for Escalon Medical's Gross Profit can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Escalon Medical Annual Data | |||||||||||||||||||||
Trend | Jun14 | Jun15 | Jun16 | Jun17 | Jun18 | Jun19 | Jun20 | Jun21 | Jun22 | Jun23 | |||||||||||
Gross Profit | Get a 7-Day Free Trial | 4.63 | 4.20 | 4.43 | 4.61 | 5.48 |
Escalon Medical Quarterly Data | ||||||||||||||||||||
Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
Gross Profit | Get a 7-Day Free Trial | 1.71 | 1.46 | 1.30 | 1.26 | 1.12 |
For the Medical Devices subindustry, Escalon Medical's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Escalon Medical's Gross Profit distribution charts can be found below:
* The bar in red indicates where Escalon Medical's Gross Profit falls into.
Gross Profit is the different between the sale prices and the cost of buying or producing the goods.
Escalon Medical's Gross Profit for the fiscal year that ended in Jun. 2023 is calculated as
Gross Profit (A: Jun. 2023 ) | = | Revenue | - | Cost of Goods Sold |
= | 12.18 | - | 6.699 | |
= | 5.48 |
Escalon Medical's Gross Profit for the quarter that ended in Mar. 2024 is calculated as
Gross Profit (Q: Mar. 2024 ) | = | Revenue | - | Cost of Goods Sold |
= | 2.696 | - | 1.579 | |
= | 1.12 |
Gross Profit for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $5.13 Mil.
Gross Profit is the numerator in the calculation of Gross Margin.
Escalon Medical's Gross Margin % for the quarter that ended in Mar. 2024 is calculated as
Gross Margin % (Q: Mar. 2024 ) | = | Gross Profit (Q: Mar. 2024 ) | / | Revenue (Q: Mar. 2024 ) |
= | (Revenue - Cost of Goods Sold) | / | Revenue | |
= | 1.12 | / | 2.696 | |
= | 41.43 % |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Escalon Medical (OTCPK:ESMC) Gross Profit Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Escalon Medical had a gross margin of 41.43% for the quarter that ended in Mar. 2024 => Durable competitive advantage
Thank you for viewing the detailed overview of Escalon Medical's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.
David James Jacovini | director | 120 PINE STREET, PHILADELPHIA PA 19106 |
John Dogum | director | 1818 MARKET STREET, 35TH FLOOR, PHILADELPHIA PA 19103 |
Richard J Depiano | director | 435 DEVON PARK DRIVE, SUITE 100, WAYNE PA 19087 |
Lisa A Napolitano | director | 351 EAST CONESTOGA ROAD, WAYNE PA 19087 |
C Sean Closkey | director | 1700 MARKET STREET, 19TH FLOOR, PHILADELPHIA PA 19103 |
C Todd Trusk | director | 1410 RUSSELL ROAD, SUITE 100, WAYNE PA 19301 |
Robert Michael O'connor | officer: Chief Financial Officer | 53 SORREL RUN, MT. LAUREL NJ 08054 |
Anthony J Coppola | director | 1 NORTH NEW YORK ROAD, SMITHVILLE NJ 08205 |
Federman Jay L Md | director | 501 N. ESSEX AVENUE, NARBERTH PA 19072 |
Kwan William L G | director | 351 EAST CONESTOGA ROAD, WAYNE PA 19087 |
Mark Wallace | officer: Chief Operating Officer | 565 E SWEDESFORD ROAD, STE 200, WAYNE PA 19087 |
Fred G Choate | director | 601 DELSEA DRIVE, WASHINGTON TOWNSHIP NJ 08080 |
Depiano Richard J Jr | officer: President | 575 E. SWEDESFORD ROAD, SUITE 100, WAYNE PA 19087 |
Berkowitz David | officer: Principal Accounting Officer | 565 EAST SWEDESFORD ROAD, SUITE 200, WAYNE PA 19087 |
Mark H Karsch | officer: CFO | 565 EAST SWEDESFORD ROAD, SUITE 200, WAYNE PA 19087 |
From GuruFocus
By gurufocus • 02-18-2009
By gurufocus 10qk • 05-20-2010
By gurufocus 10qk • 10-12-2010
By gurufocus • 05-15-2009
By gurufocus 10qk • 11-15-2010
By gurufocus 10qk • 11-16-2009
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.